• Home
  • NEW DAY MEDICINE
  • 5 (67) 2024
  • 102 -5 (67) 2024 - Abdullayeva F.O. - THE ESSENCE OF TUBERCULOSIS, PREVENTION, A NEW LOOK AT THE REABILATIZATION OF THE RESPIRATORY TRACT

102 -5 (67) 2024 - Abdullayeva F.O. - THE ESSENCE OF TUBERCULOSIS, PREVENTION, A NEW LOOK AT THE REABILATIZATION OF THE RESPIRATORY TRACT

THE ESSENCE OF TUBERCULOSIS, PREVENTION, A NEW LOOK AT THE REABILATIZATION OF THE RESPIRATORY TRACT

Abdullayeva F.O. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The respiratory tract is the point of contact of the body with the external environment, it carries out the exchange of gases and is widely affected by various antigens of plants and animals. the most important mechanism for the elimination of tuberculous mycobacteria (MBT) in the human body is phagocytosis provided by neutrophils and alveolar macrophages. There is no idea how to cope with resistance to antigenic effects , at which cellular levels (alveolar macrophages, DC or regulatory T cells) the main failure occurs, and strong inflammation occurs in 5-10% of infected people who are prone to the development of clinical forms of tuberculosis. Consequently, as for the pathogenesis of the appearance of emptiness, there are currently not enough harmonious ideas that reveal a sequential chain of events. It is clear that this process should begin with necrosis of lung tissue, which can include various cellular elements that produce collagenase proteases that destroy the matrix, such as MMP-1 and MMP-8. In the early stages, in most cases, the necessary condition is pronounced HRT, which clearly enhances the inflammatory component of the immune response.

Key words: Tuberculosis is a global threat to humanity, death from infections, treatment of tuberculosis diseases.

First page

589

Last page

599

For citation:Abdullayeva F.O. - THE ESSENCE OF TUBERCULOSIS, PREVENTION, A NEW LOOK AT THE REABILATIZATION OF THE RESPIRATORY TRACT//New Day in Medicine 5(67)2024 589-599 https://newdayworldmedicine.com/en/article/3758

List of References

  1. UNAIDS/Newsletter for the year 2015. http://www.unaids.org/ sites/default/files/media_asset/20150901_FactSheet_2015_ru.pd. (date of access: 10.09.2017)
  2. Global Tuberculosis Report 2015. Geneva : World Health Organization, 2015. http://www.who.int/tb/publications/ru/ (date of access: 10.09.2017)
  3. Raviolione M.K., Korobitsyn A.A. End ТВ – The new WHO strategy in the sdg era, and the contributions from the Russian Federation. Tuberkulez i bo lezni legkikh [Tuberculosis and Lung Diseases]. 2016;(11):7-15. (in Russian)
  4. Anti-TB work in Moscow. Analytical review of statistical indicators for tuberculosis, 2015. Edited by Bogorodskaya E.M., Litvinov V.I., Bel ilovskiy E.M. Мoscow: Moscow Municipal Scientific and Practical Center for Struggle against Tuberculosis of Moscow Department of Health Care, 2016: 244 p. (in Russian)
  5. Tuberculosis in the Russian Federation, 2012/2013/2014. Ana lytical review of statistical indicators used in the Russian Federation and in the world. Мoscow, 2015: 312 p. (in Russian)
  6. Nechaeva O.B. Epidemic situation in tuberculosis in the Russian Federation (main trends). Federal Center for Monitoring Counteraction to Tuberculosis Spread in the Russian Federation. FSBI «Central Scientific Research Institute of Health Organization and Informatization» 2015. http://www.mednet.ru/images/stories/files/CMT/epid_situaciya_sezd_ ftiziatrov.pdf. (date of access: 10.09.2017) (in Russian)
  7. Bogorodskaya E.M., Sinitsyn M.V., Belilovskiy E.M., Borisov S.E., et al. Impact of HIV-infection on structure of tuberculosis incidence in megacity conditions. Tuberkulez i sotsial'no znachimye zabolevaniya [Tu berculosis and Socially Significant Diseases]. 2016; (3):3–17. (in Russian)
  8. Pokrovsky V.I., Litvinov V.I., Lovacheva O.V., Lazareva O.L. Tubercu lous meningitis. Мoscow, 2005: 244 p. (in Russian)
  9. Futer D.S. Differential diagnosis and treatment of tuberculous men ingitis. Мoscow: Medgiz, 1954: 171 p. (in Russian)
  10. Sevost'yanova T.A., Klimov G.V., Shirshov I.V., Vlasova E.E. Tu berculous meningitis in children of tender age. Tuberkulez i sotsial'no znachimye zabolevaniya [Tuberculosis and Socially Significant Diseases]. 2014; (5):32–9. (in Russian)
  11. Kornilova Z.Kh., Savin A.A., Vigriyanov V.Yu., Zyuzya Yu.R., et al. The tuberculous meningoencephalitis in patients with later stages of HIV infection. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [S.S. Kor sakov Journal of Neurology and Psychiatry]. 2013; (12):13–8. (in Russian)
  12. Shmeriga G.S., Sinitsyn M.V. Tuberculous meningoencephalitis in patients with HIV-infection: diagnosis and flow characteristics. Tuberkulez i sotsial'no znachimye zabolevaniya [Tuberculosis and Socially Significant Diseases]. 2016; (3):67–8. (in Russian)
  13. Epi Info™ Help Desk Centers for Disease Control and Prevention. http://wwwn.cdc.gov/epiinfo/ 2016) (date of access: 10.09.17)
  14. Gayda A.I., Sveshnikova O.M., Verkhovaya V.N., Makhmaeva S.V., Nikishova E.I., Maryandyshev A.O. Treatment of tuberculosis patients with extensive drug resistance using new anti-tuberculosis drugs in the civilian community of Arkhangelsk Region. Tuberculosis and Lung Diseases, 2018;96(7):5-10. (In Russ.)
  15. Zhdanova E.V., Turdumambetova G.K. Short-course chemotherapy regimen of multidrug-resistant tuberculosis in the Kyrgyz Republic. Vestnik Avitsenny, 2018, no. 2-3. (In Russ.) Available: https://cyberleninka.ru/article/n/ lechenie-tuberkulyoza-s-mnozhestvennoy-lekarstvennoy-ustoychivostyu-kratkosrochnymi-shemami-himioterapii-v-kyrgyzskoy-respublike Accessed March 24, 2023.
  16. Maryandyshev A.O., Lorsanov S.M., Khaydarkhanova Z.B., Khunkarsultanov S.B., Perkhin D.V., Sveshnikova O.M., Gayda A.I., Privolnev V.V. Treatment outcomes of regimens containing delamanid within therapy of multiple and extensive drug resistant tuberculosis in the Russian Federation. Tuberculosis and Lung Diseases, 2019, vol. 97, no. 11, pp. 67-68. (In Russ.)
  17. Mozhokina G.N., Samoylova A.G. Clofazimine: history and perspectives. Tuberculosis and Lung Diseases, 2021, vol. 99, no. 5, pp. 64-70. (In Russ.) 5. Nikolenko N.Yu., Kudlay D.A., Borisov S.E., Sannikova T.E., Doctorova N.P. Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance. Farmakoekonomika, Modern Pharmacoeconomics and Pharmacoepidemiology, 2023, no. 16(2), pp. 162-175. (In Russ.) https://doi. org/10.17749/2070-4909/farmakoekonomika.2023.179.
  18. Nikolenko N.Yu., Kudlay D.A., Doctorova N.P. Pharmacoepidemiology and pharmacoeconomics of multiple and extensive drug resistant tuberculosis. Farmakoekonomika, Modern Pharmacoeconomics and Pharmacoepidemiology, 2021, no. 14(2), pp. 235-248. (In Russ.) https://doi. org/10.17749/2070-4909/farmakoekonomika.2021.089.
  19. Tuberculosis profile: Russian Federation, 2021. (In Russ.) WHO: https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&entity_type=%2 2country%22&lan=%22EN%22&iso2=%22RU%22 Accessed 14.03.2023 г.]
  20. Stavitskaya N.V., Felker I.G., Zhukova E.M., Tlif A.I., Doctorova N.P., Kudlay D.A. The multivariate analysis of the results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis. Tuberculosis and Lung Diseases, 2020, no. 98(7), pp. 56-62. (In Russ.)

    file

    download